Peg L Aspatero 3750IU Injection

Product Description

Peg L Aspatero 3750IU Injection contains Asparaginase. It is mainly used to treat lymphoblastic lymphoma and acute lymphoblastic leukemia (ALL).

Tell your doctor if you are pregnant, planning to get pregnant, or nursing a baby because this medication may impair your immune system, raise your risk of infection, and necessitate effective contraception.

Brand Name: Peg L Aspatero

Composition: Asparaginase

Mechanism of Action:

Asparagine is hydrolyzed by pegaspargase to produce ammonia and aspartic acid. For cancer cells, asparagine is a necessary amino acid, particularly in some types of cancer like ALL. Pegaspargase efficiently starves the cancer cells, preventing their development and multiplication by lowering the blood levels of asparagine.

Uses:

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Dosage and Administration:

Peg L. Aspatero is typically administered intravenously (IV) or intramuscularly (IM) at a dose of 3750 IU/m body surface area. Usually administered every 14 or 21 days, the dosage frequency varies depending on the particular treatment plan.

Side Effects:

• Nausea
• Vomiting
• Fever
• Anorexia
• Rash or skin reactions at the injection site
• Rash
• Hives
• Anaphylaxis